Search details
1.
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2.
BMC Cancer
; 18(1): 1007, 2018 Oct 20.
Article
in English
| MEDLINE | ID: mdl-30342473
2.
miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance.
J Biol Chem
; 288(6): 4334-45, 2013 Feb 08.
Article
in English
| MEDLINE | ID: mdl-23255607
3.
Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report.
Transplant Proc
; 54(1): 193-196, 2022.
Article
in English
| MEDLINE | ID: mdl-35012763
4.
Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.
J Immunol
; 183(10): 6800-7, 2009 Nov 15.
Article
in English
| MEDLINE | ID: mdl-19846868
5.
Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study.
Adv Radiat Oncol
; 6(6): 100798, 2021.
Article
in English
| MEDLINE | ID: mdl-34934864
6.
Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia.
Cancer Med
; 10(21): 7665-7672, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34590788
7.
Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma.
BMC Med
; 8: 14, 2010 Feb 17.
Article
in English
| MEDLINE | ID: mdl-20163701
8.
Activated CD4+ T cells enhance radiation effect through the cooperation of interferon-gamma and TNF-alpha.
BMC Cancer
; 10: 60, 2010 Feb 23.
Article
in English
| MEDLINE | ID: mdl-20178622
9.
Recurrence risk of early-stage melanoma of the external ear: an investigation of surgical approach and sentinel lymph node status.
Melanoma Res
; 30(2): 173-178, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31219456
10.
The Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game Theory.
JCO Clin Cancer Inform
; 3: 1-12, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30742484
11.
Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma.
Sci Rep
; 8(1): 4044, 2018 03 06.
Article
in English
| MEDLINE | ID: mdl-29511262
12.
Narcoleptic-like Episodes in a Patient Receiving Pegylated Interferon-alpha 2b: A Case Report and Review of Literature.
Anticancer Res
; 37(3): 1365-1368, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28314304
13.
Complete response to azacitidine priming and nab-paclitaxel in non-Hodgkin lymphoma resistant to biochemotherapy.
Mol Clin Oncol
; 6(1): 122-124, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-28123744
14.
A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors.
Oncotarget
; 8(32): 52413-52419, 2017 Aug 08.
Article
in English
| MEDLINE | ID: mdl-28881739
15.
Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.
Oncotarget
; 8(19): 32171-32189, 2017 May 09.
Article
in English
| MEDLINE | ID: mdl-28418870
16.
A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
Clin Breast Cancer
; 17(7): 503-509, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28579139
17.
Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy.
Oncogene
; 24(33): 5226-34, 2005 Aug 04.
Article
in English
| MEDLINE | ID: mdl-15897911
18.
The Waardenburg syndrome type 4 gene, SOX10, is a novel tumor-associated antigen identified in a patient with a dramatic response to immunotherapy.
Cancer Res
; 62(11): 3020-3, 2002 Jun 01.
Article
in English
| MEDLINE | ID: mdl-12036907
19.
A Case Report of Pneumocystis Jiroveci Pneumonia in a Patient with Metastatic Breast Cancer.
Anticancer Res
; 36(12): 6673-6676, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27920001
20.
miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20.
Oncotarget
; 7(48): 78667-78679, 2016 Nov 29.
Article
in English
| MEDLINE | ID: mdl-27637078